Impact of primary aldosteronism on calcium phosphate homeostasis. Results from the SPAIN-ALDO.
Iriarte-Durán MB, Paja Fano M, Rizo Gellida A, González-Boillos M, Parra Ramírez P, Martín Rojas-Marcos P, Caja L, García Cano AM, Ruiz-Sanchez JG, Vicente A, Gómez-Hoyos E, Recasens M, Barahona San Millan R, Picón César MJ, Díaz Guardiola P, Perdomo CM, Manjón-Miguélez L, Rebollo Román Á, Robles Lázaro C, Recio JM, Calatayud M, Jiménez López N, Sampedro Nuñez M, Mena Ribas E, Sanmartín Sánchez A, Gonzalvo Diaz C, Lamas C, Serrano J, Michalopoulou T, Tenes Rodrigo S, Jaén Aguila F, Moya Mateo EM, Gutiérrez-Medina S, Hanzu FA, Araujo-Castro M.
Iriarte-Durán MB, et al.
J Endocrinol Invest. 2025 Jul;48(7):1611-1622. doi: 10.1007/s40618-025-02563-y. Epub 2025 Apr 19.
J Endocrinol Invest. 2025.
PMID: 40252188
METHODS: A retrospective multicenter study of primary aldosteronism (PA) patients followed in 37 Spanish tertiary hospitals and with available information on serum calcium, phosphorus, iPTH, and vitamin D at the time of PA diagnosis. The diagnosis of normocalcemic HPT (n-H …
METHODS: A retrospective multicenter study of primary aldosteronism (PA) patients followed in 37 Spanish tertiary hospitals and with availab …